Scilex Holding Co

SCLX Nasdaq CIK: 0001820190

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
Mailing Address 960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
Phone (650) 516-4310
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2024

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
8-K Current report of material events February 3, 2026 View on SEC
8-K Current report of material events February 2, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 14, 2026 View on SEC
4 Insider stock transaction report January 14, 2026 View on SEC
4 Insider stock transaction report January 8, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 8, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment December 31, 2025 View on SEC
4/A Insider transaction amendment December 31, 2025 View on SEC
4 Insider stock transaction report December 30, 2025 View on SEC

Material Events

8-K Strategy Change February 2, 2026
High Impact
  • Scilex Holding Co. made a nearly $50 million strategic investment in Quantum Scan Holdings, Inc.
  • This investment signals a potential strategic shift for Scilex beyond its traditional pain relief drug development.
View Analysis

Insider Trading

STRONG SELL 1 insiders 3 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.